Sign up to save your podcasts
Or
Share Idaho Matters Doctors Roundtable: September 20, 2023
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Idaho Matters Doctors Roundtable: September 20, 2023
A generic of EpiPen, an epinephrine injection auto-injector, used for allergic reactions.(Tony Webster / Flickr)
In a surprise move yesterday the FDA put the brakes on a new drug that was supposed to take the place of EpiPen's to treat anaphylactic shock. And a nasty new virus is making the rounds in India.
Dr. David Pate, former CEO of St. Luke's Health System, joined Idaho Matters to talk more.
View all episodes
By Boise State Public Radio
4.5
102102 ratings
A generic of EpiPen, an epinephrine injection auto-injector, used for allergic reactions.(Tony Webster / Flickr)
In a surprise move yesterday the FDA put the brakes on a new drug that was supposed to take the place of EpiPen's to treat anaphylactic shock. And a nasty new virus is making the rounds in India.
Dr. David Pate, former CEO of St. Luke's Health System, joined Idaho Matters to talk more.
More shows like Idaho Matters
View all
This American Life
90,994 Listeners
Radiolab
43,898 Listeners
Fresh Air
38,062 Listeners
Hidden Brain
43,528 Listeners
Wait Wait... Don't Tell Me!
38,856 Listeners
On the Media
9,237 Listeners
On Point with Meghna Chakrabarti
3,998 Listeners
Reveal
8,454 Listeners
Science Vs
12,237 Listeners
Science Friday
6,435 Listeners
1A
4,681 Listeners
Throughline
16,399 Listeners
Idaho Reports
10 Listeners
Extremely American
436 Listeners
The Connector: Idaho Daily News
9 Listeners